Revvity Inc (RVTY)
108.46
+1.15
(+1.07%)
USD |
NYSE |
May 16, 16:00
108.46
0.00 (0.00%)
After-Hours: 20:00
Revvity Cash from Investing (Quarterly): -18.18M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -18.18M |
December 31, 2023 | -414.81M |
September 30, 2023 | 434.87M |
June 30, 2023 | -571.04M |
March 31, 2023 | 1.865B |
December 31, 2022 | -25.68M |
September 30, 2022 | -22.51M |
June 30, 2022 | -28.36M |
March 31, 2022 | -56.31M |
December 31, 2021 | -59.95M |
September 30, 2021 | -3.301B |
June 30, 2021 | -290.02M |
March 31, 2021 | -461.85M |
December 31, 2020 | -436.40M |
September 30, 2020 | -22.52M |
June 30, 2020 | -23.56M |
March 31, 2020 | -22.01M |
December 31, 2019 | -172.03M |
September 30, 2019 | -29.02M |
June 30, 2019 | -257.29M |
March 31, 2019 | -29.23M |
December 31, 2018 | -87.96M |
September 30, 2018 | 8.019M |
June 30, 2018 | -56.25M |
March 31, 2018 | -23.67M |
Date | Value |
---|---|
December 31, 2017 | -1.454B |
September 30, 2017 | 45.33M |
June 30, 2017 | 271.82M |
March 31, 2017 | -129.84M |
December 31, 2016 | -5.693M |
September 30, 2016 | -70.43M |
June 30, 2016 | 9.532M |
March 31, 2016 | -17.29M |
December 31, 2015 | -65.12M |
September 30, 2015 | -6.958M |
June 30, 2015 | -19.74M |
March 31, 2015 | -9.039M |
December 31, 2014 | -272.08M |
September 30, 2014 | -9.231M |
June 30, 2014 | -8.565M |
March 31, 2014 | -6.02M |
December 31, 2013 | -16.08M |
September 30, 2013 | 37.05M |
June 30, 2013 | -11.88M |
March 31, 2013 | -10.31M |
December 31, 2012 | -51.86M |
September 30, 2012 | -18.19M |
June 30, 2012 | -5.033M |
March 31, 2012 | -5.228M |
December 31, 2011 | -607.44M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.301B
Minimum
Sep 2021
1.865B
Maximum
Mar 2023
-195.66M
Average
-42.66M
Median
Cash from Investing (Quarterly) Benchmarks
Agilent Technologies Inc | -95.00M |
Bruker Corp | -304.20M |
Azenta Inc | -270.61M |
Harvard Bioscience Inc | -0.225M |
Bionano Genomics Inc | 47.59M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 147.56M |
Cash from Financing (Quarterly) | -35.01M |
Free Cash Flow | 97.11M |
Free Cash Flow Per Share (Quarterly) | 1.05 |
Free Cash Flow to Equity (Quarterly) | 152.92M |
Free Cash Flow to Firm (Quarterly) | 133.30M |
Free Cash Flow Yield | 0.72% |